ARHS
Arhaus, Inc.
ARHS has a slight edge over RIVN overall on the model score.
RIVN
Rivian Automotive, Inc.
RIVN has lower modeled downside risk, despite its lower overall score.
ARHS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Strong |
ARHS's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ARHS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $4.81 | -64% |
| Fair | 18x | $8.20 | -39% |
| Expensive | 22x | $10.24 | -24% |
| Forward | 24x | $13.52 | — |
| Current | 29x | $13.52 | — |
Historical ranges are pointers, not guarantees.
ARHS's PE is in its expensive range at 29x. If earnings grow as analysts expect, today's price would be 24x next year's earnings.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
ARHS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for ARHS, with profitability improving. However, they disagree widely on these estimates.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RIVN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ARHS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.56 | +22% |
| Q3 2026 | $0.46 | -12% |
| Q2 2026 | $0.50 | 0% |
| Q1 2026 | $0.47 | +15% |
| Q4 2025 | $0.48 | -2% |
| Q3 2025 | $0.52 | -7.1% |
| Q2 2025 | $0.50 | -21% |
| Q1 2025 | $0.41 | -46% |
| Q4 2024 | $0.49 | -45% |
ARHS has the edge over RIVN on earnings quality, reporting a profit while its opponent remains loss making.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
ARHS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $368.1M | +6.8% |
| Q2 2026 | $384.9M | +7.4% |
| Q1 2026 | $314.3M | +0.9% |
| Q4 2025 | $364.8M | +5.1% |
| Q3 2025 | $344.6M | +8% |
| Q2 2025 | $358.4M | +16% |
| Q1 2025 | $311.4M | +5.5% |
| Q4 2024 | $347M | +0.9% |
ARHS's revenue has grown year over year for eight quarters in a row: $368M last quarter, up 6.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.7% | -2 points |
| Q2 2026 | 14% | +1 points |
| Q1 2026 | 0.7% | -1.1 points |
| Q4 2025 | 5.5% | -2.7 points |
| Q3 2025 | 4.8% | +1.4 points |
| Q2 2025 | 13% | +3.6 points |
| Q1 2025 | 1.7% | -4.5 points |
| Q4 2024 | 8.2% | -3.7 points |
ARHS has the edge over RIVN on profitability, with a higher operating margin.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN's revenue is growing: $2.2B last quarter, up 38% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
ARHS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $91.9M | +228% |
| Q2 2026 | $48.3M | +131% |
| Q1 2026 | -$26.6M | -241% |
| Q4 2025 | -$8.8M | -168% |
| Q3 2025 | $28M | +509% |
| Q2 2025 | $20.9M | +86% |
| Q1 2025 | $18.9M | +73% |
| Q4 2024 | $13M | +$26.8M |
ARHS has the edge over RIVN on cash generation, producing positive trailing cash flow while its opponent burns cash.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
ARHS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.3x | Net Cash |
| Q2 2026 | -1.6x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -1.9x | Net Cash |
| Q3 2025 | -1.8x | Net Cash |
| Q2 2025 | -1.7x | Net Cash |
| Q1 2025 | -1.9x | Net Cash |
| Q4 2024 | -1.6x | Net Cash |
ARHS has more cash than debt.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ARHS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 69.0 | Neutral |
| Stochastic | 90.6 | Overbought |
ARHS's weekly RSI is 69 (neutral) and its Stochastic is 91 (overbought).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
ARHS PE vs Consumer Cyclical Sector
| Metric | ARHS | Sector median | Relative |
|---|---|---|---|
| PE | 29x | 18x | 63% above |
| PE % | 96 | 56 | 40 pts above |
ARHS is trading at 29x earnings, a 63% premium to the Consumer Cyclical sector's median of 18x.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
ARHS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.4 | 18% above |
| 20 week MA | $9.67 | 40% above |
| 50 week MA | $8.97 | 51% above |
| 100 week MA | $9.41 | 44% above |
| 200 week MA | $10.5 | 29% above |
ARHS has the edge over RIVN on trend strength, trading above more of its moving averages.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
ARHS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $12.2 | $10.4 | -15% |
| 2022 | $10.4 | $9.24 | -11% |
| 2023 | $9.24 | $11.9 | +28% |
| 2024 | $11.9 | $9.26 | -22% |
| 2025 | $9.26 | $11.7 | +27% |
| 2026 YTD | $11.7 | $13.5 | +15% |
ARHS has the edge over RIVN on returns for 2026, with the stronger performance.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has finished lower in three of the last five years. It's down 39% so far in 2026.